简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-06-18 10:53 Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)
2025-06-16 17:36 HekaBio, Japan-based Biopharma and MedTech Platform, Enters Strategic Partnership with Alfresa Holdings Corporation
2025-06-16 10:54 Kao Releases the Kao Integrated Report 2025
2025-06-13 17:42 HOYA Vision Care Unveils Updates from the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting
2025-06-13 15:13 Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies
2025-06-13 14:53 New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia
2025-06-13 10:16 Merck Presents Results on Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus (SLE) at EULAR 2025
2025-06-13 09:14 FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025
2025-06-11 10:18 HistoSonics and Cambridge University Unveil Europe’s First Edison™ Histotripsy System Powered by Li Ka Shing Foundation Gift
2025-06-11 09:50 Medisca Secures Settlement With FlackTek, Reinforcing Patent Strength of MAZ® Mixer
2025-06-11 09:30 Novotech Showcased in Global Biotech Series for Innovation in Hepatitis B Research
2025-06-11 09:26 Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults
2025-06-10 12:37 China’s Center for Drug Evaluation Accepts Merck’s Application for Marketing Authorization of Pimicotinib for Treatment of Tenosynovial Giant Cell Tumor
2025-06-09 10:27 HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors
2025-06-06 14:44 iFIT Adds More Ways to Workout, Brings Club Pilates and YogaSix Content to Its Platform
2025-06-06 14:06 RAD 2025: Long-Term Data on Nemluvio® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to Two Years
2025-06-06 11:32 QPS Celebrates 30th Anniversary
2025-06-06 11:25 Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research
2025-06-06 11:22 Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Patent Portfolio for RenMice Fully Human Antibody/TCR Platform
2025-06-05 16:15 Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US

Business Wire Weibo

Press Releases

Latest Releases